Supported cancer types

IndiTreat^® is for cancer therapy selection

With IndiTreat®, you can test different panels of drugs and drug combinations on microtumors derived from individual patients to identify resistance and sensitivity.

IndiTreat® CE IVD Colorectal Cancer Test

A method of determining which drugs offer the most suitable therapies for different patients with stage III–IV colorectal cancer, this test can be used before:

• Postoperative adjuvant therapy
• Neoadjuvant therapy
• 1st and 2nd line therapy of metastatic disease
• Therapy of end-stage metastatic patients
• HIPEC (hyperthermic intraperitoneal chemotherapy)

IndiTreat® Ovarian Cancer Test

This test indicates which panels offer the most suitable therapies for different patients with ovarian cancer. Multi-center clinical validation trials are ongoing. This test is used before:

• Postoperative adjuvant therapy
• Neoadjuvant therapy
• Therapy of recurrence regardless of previous platinum response
• Selection of the most effective PARP-inhibitor in BRCA-mt patients
• Selection of BRCA-wt patients who shall benefit from PARP-inhibition
• Therapy of end-stage patients

IndiTreat® Pancreatic Cancer Test

A method of determining which drugs offer the most suitable therapies for different patients with pancreatic cancer. Multi-center clinical validation trials are ongoing. This test is used before:

• Postoperative adjuvant therapy
• Neoadjuvant therapy if a pancreatic biopsy is feasible
• 1st and 2nd line palliative therapy